At a regular press briefing in Geneva, Tedros stressed that simple public health measures work even in the presence of variants
"But we must keep up the pressure to meet the needs of priority populations everywhere and facilitate global access. To do that, we need two things – a scale-up of manufacturing capacity, and developers’ early submission of their vaccines for WHO review," the WHO official told reporters.
Noting a nearly 50 per cent drop this year, he said that the world's respond to this trend is what matters now.
Ensuring the rapid and equitable rollout of vaccines globally is essential for saving lives, stabilizing health systems, protecting livelihoods and steadying economies, according to the WHO chief.
WHO has issued the green light for two versions of the Oxford-AstraZeneca vaccine to be rolled out globally under an emergency listing, which assesses and assures the quality, safety and efficacy of covid-19 vaccines and is also a distribution prerequisite under the UN-led vaccine initiative COVAX
Following the Pfizer-BioNTech inoculations, these are the second and third vaccines to receive emergency use listing.